Newer drug therapies for multiple sclerosis

J. L. Carter, M. Rodriguez

Research output: Contribution to journalArticle

Abstract

Multiple sclerosis (MS) is a disease of unknown etiology that is felt by many to be immunologically mediated. Corticosteroids have historically been used to treat acute exacerbations of MS and remain the treatment of choice, although new therapies for acute attacks are under development. Several immunosuppressive therapies have shown limited benefit in chronic progressive MS, and these modalities are reviewed in this article. Finally, several new drugs have shown promise in the symptomatic treatment of MS and are also reviewed.

Original languageEnglish (US)
Pages (from-to)31-43
Number of pages13
JournalDrug Therapy
Volume20
Issue number3
StatePublished - 1990
Externally publishedYes

Fingerprint

Multiple Sclerosis
Drug Therapy
Chronic Progressive Multiple Sclerosis
Therapeutics
Immunosuppressive Agents
Adrenal Cortex Hormones
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Carter, J. L., & Rodriguez, M. (1990). Newer drug therapies for multiple sclerosis. Drug Therapy, 20(3), 31-43.

Newer drug therapies for multiple sclerosis. / Carter, J. L.; Rodriguez, M.

In: Drug Therapy, Vol. 20, No. 3, 1990, p. 31-43.

Research output: Contribution to journalArticle

Carter, JL & Rodriguez, M 1990, 'Newer drug therapies for multiple sclerosis', Drug Therapy, vol. 20, no. 3, pp. 31-43.
Carter JL, Rodriguez M. Newer drug therapies for multiple sclerosis. Drug Therapy. 1990;20(3):31-43.
Carter, J. L. ; Rodriguez, M. / Newer drug therapies for multiple sclerosis. In: Drug Therapy. 1990 ; Vol. 20, No. 3. pp. 31-43.
@article{831c5696db6a43bbbb334331cd5a2a26,
title = "Newer drug therapies for multiple sclerosis",
abstract = "Multiple sclerosis (MS) is a disease of unknown etiology that is felt by many to be immunologically mediated. Corticosteroids have historically been used to treat acute exacerbations of MS and remain the treatment of choice, although new therapies for acute attacks are under development. Several immunosuppressive therapies have shown limited benefit in chronic progressive MS, and these modalities are reviewed in this article. Finally, several new drugs have shown promise in the symptomatic treatment of MS and are also reviewed.",
author = "Carter, {J. L.} and M. Rodriguez",
year = "1990",
language = "English (US)",
volume = "20",
pages = "31--43",
journal = "Drug Therapy",
issn = "0001-7094",
number = "3",

}

TY - JOUR

T1 - Newer drug therapies for multiple sclerosis

AU - Carter, J. L.

AU - Rodriguez, M.

PY - 1990

Y1 - 1990

N2 - Multiple sclerosis (MS) is a disease of unknown etiology that is felt by many to be immunologically mediated. Corticosteroids have historically been used to treat acute exacerbations of MS and remain the treatment of choice, although new therapies for acute attacks are under development. Several immunosuppressive therapies have shown limited benefit in chronic progressive MS, and these modalities are reviewed in this article. Finally, several new drugs have shown promise in the symptomatic treatment of MS and are also reviewed.

AB - Multiple sclerosis (MS) is a disease of unknown etiology that is felt by many to be immunologically mediated. Corticosteroids have historically been used to treat acute exacerbations of MS and remain the treatment of choice, although new therapies for acute attacks are under development. Several immunosuppressive therapies have shown limited benefit in chronic progressive MS, and these modalities are reviewed in this article. Finally, several new drugs have shown promise in the symptomatic treatment of MS and are also reviewed.

UR - http://www.scopus.com/inward/record.url?scp=0025287216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025287216&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0025287216

VL - 20

SP - 31

EP - 43

JO - Drug Therapy

JF - Drug Therapy

SN - 0001-7094

IS - 3

ER -